(Q42205633)

18 October 2017

Biotransformation of selected gyrase inhibitors (English)

1 reference

18 October 2017

K Borner

1

1 reference

PubMed ID

3007367

18 October 2017

H Lode

series ordinal

2

1 reference

PubMed ID

3007367

18 October 2017

language of work or name

German

0 references

publication date

1 January 1986

1 reference

18 October 2017

1 reference

18 October 2017

14 Suppl 1

1 reference

18 October 2017

S54-9

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01645200

18 October 2017

0 references

cites work

[Effectiveness, dosage and toxic effects of piperazine preparations]

1 reference

12 December 2020

Formation of identical metabolites from piperazine- and dimethylamino-substituted phenothiazine drugs in man, rat and dog

1 reference

12 December 2020

The human biotransformation of nalidixic acid

1 reference

12 December 2020

High-performance liquid chromatographic procedure for the quantitation of norfloxacin in urine, serum and tissues

1 reference

12 December 2020

ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID

1 reference

12 December 2020

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01645200

1 reference

18 October 2017

1 reference

PubMed ID

3007367